ValueQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMSelling/general/admin expenses251.25 M247.78 M259.79 M265.09 M275.68 M1.05 BResearch & development57.73 M59.06 M61.9 M63.41 M66.83 M251.21 M영업 이익261.69 M316.53 M373.05 M354.85 M315.61 M1.36 BNon-Operating Income, Total——————Interest expense, net of interest capitalized7.5 M7.67 M11.32 M10.65 M9.21 M38.85 MNon-Operating Income, excl. Interest Expenses——————Unusual income/expense——————Pretax income256.39 M310.08 M362.35 M344.77 M306.98 M1.32 BEquity in earnings——————Taxes40.24 M67.41 M68.36 M70.16 M58.79 M264.73 MNon-controlling/minority interest——————After tax other income/expense——————Net income before discontinued operations216.15 M242.68 M293.99 M274.61 M248.19 M1.06 BDiscontinued operations——————Net income216.15 M242.68 M293.99 M274.61 M248.19 M1.06 BDilution adjustment——————Preferred dividends——————Diluted net income available to common stockholders216.15 M242.68 M293.99 M274.61 M248.19 M1.06 BBasic earnings per share (Basic EPS)2.642.983.663.433.113.17Diluted earnings per share (Diluted EPS)2.622.963.633.43.0913.08Average basic shares outstanding82.47 M81.32 M80.41 M80.1 M80.43 M322.25 MDiluted shares outstanding83.25 M81.92 M80.99 M80.67 M81.03 M324.62 MEBITDA291.82 M347.71 M405.88 M388.24 M349.43 M1.49 BEBIT258.11 M313.64 M370.11 M351.61 M310.7 M1.35 BCost of revenue385.42 M375.05 M416.19 M423.5 M434.92 M1.65 BOther cost of goods sold——————Depreciation & amortization (cash flow)33.71 M34.06 M35.77 M36.63 M38.72 M145.18 M
IDEXX Laboratories Inc
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions.
IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.